Qiagen stock: Berenberg raises target for Qiagen stock to USD 52.22

Published on 10/23/2026 at 17:09 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Q3 sales reached USD 548 million on October 21, 2026. Qiagen stock costs EUR 45.02 on October 23, 2026, up 0.18 percent versus the Xetra close.

Analyst target and earnings date

Berenberg raised its Qiagen target from USD 45.50 to USD 52.22 on October 22, 2026.
Preliminary third-quarter sales reached USD 548.00 million on October 21, 2026.
Qiagen stock costs EUR 45.02 at Lang & Schwarz on October 23, 2026 at 5:03 p.m. CEST, 0.18 percent above the Xetra close of October 22, 2026, and 5.42 percent below the 52-week high.
Qiagen plans to publish full third-quarter results on November 4, 2026.

Pipette tropft klare Flüssigkeit in sterile 96-Well-Platte, klinisches Laborlicht — Qiagen N.V. (NL0012169213) Pipette tropft klare Flüssigkeit in sterile 96-Well-Platte im klinischen Labor, Illustration mit AI erstellt.

QIAGEN raised its analyst focus after MarketScreener reported on October 22, 2026 that Berenberg lifted its price target from USD 45.50 to USD 52.22 and kept a Hold rating. The target stands 3.61 percent above the USD 50.40 primary-market price used for the comparison. Qiagen stock was trading at EUR 45.02 at Lang & Schwarz on October 23, 2026 at 5:03 p.m. CEST, up 0.18 percent versus the Xetra close of October 22, 2026 at EUR 44.94.

Third-quarter sales reach USD 548 million

QIAGEN reported preliminary third-quarter 2026 net sales of USD 548.00 million and adjusted diluted earnings per share of USD 0.65 on October 21, 2026. Both figures were reported at the same level on a constant-exchange-rate basis. The company also suspended its full-year 2026 outlook while the pending transaction remains unresolved, according to Qiagen.

Stock sits 5.42 percent below its high

The Xetra-linked euro quotation spans EUR 27.56 to EUR 47.60 over the past 52 weeks as of October 23, 2026. At EUR 45.02, the stock stands 5.42 percent below that high. Trading volume reached 1,673,669 shares, while the market capitalization was EUR 9.3 billion and the price-to-earnings ratio was 25.86.

November 4 brings the next results

QIAGEN plans to publish its complete third-quarter results on November 4, 2026, at 10:05 p.m. Frankfurt time, according to its October 21 release. The company serves more than 500,000 customers and employs about 5,400 people across more than 35 locations, according to its investor-relations materials. For investors, the combination of a defined reporting date and suspended full-year outlook leaves the next earnings release as the clearest scheduled measurement point.

Price and target tell different stories

Berenberg's USD 52.22 target is above the USD 50.40 primary-market price, while the euro quotation remains below the October 22 Xetra close by EUR 0.08. The separate currencies matter: the analyst target is stated in USD, whereas the German trading quotation and its daily comparison are in EUR.

Trading remains near the yearly high

The latest euro quotation places Qiagen below its 52-week high but well above its 52-week low. The next company report on November 4 will provide the next dated operating update and may clarify how the suspended full-year outlook is handled.

Qiagen was trading at EUR 45.02 at Lang & Schwarz on October 23, 2026 at 5:03 p.m. CEST, 0.18 percent above the Xetra close of October 22, 2026 at EUR 44.94. The further course of trading is shown by the continuously updated real-time quote of Qiagen stock.